Skip to content
healthcare.dev

Terazosin

NDC 66267-389, Terazosin Hydrochloride, capsule, from NuCare Pharmaceuticals, Inc..

Product NDC
66267-389
Status
Listed
Labeler
NuCare Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075317
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66267-389 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
66267-389-906626703899090 CAPSULE in 1 BOTTLE (66267-389-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/40e5ae44-708a-15a3-e054-00144ff8d46c

Use it

Look up 66267-389 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66267-389 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66267-389. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.